A carregar...
Research progress in immune checkpoint inhibitors for lung cancer in China
Immune checkpoint inhibitors (ICIs) have come to play an increasingly prominent role in the treatment of lung cancer, and some are recommended as a first-line treatment for late-stage non-small-cell lung cancer, either as a monotherapy or in combination with chemotherapy. Accordingly, the indication...
Na minha lista:
| Publicado no: | Ther Adv Med Oncol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8295948/ https://ncbi.nlm.nih.gov/pubmed/34349843 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/17588359211029826 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|